Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective, less costly, or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

Contact
The Investor Relations Group:
Erika Moran, Investor Relations
Janet Vasquez, Public Relations
(212) 825-3210

FINANCIAL TABLES FOLLOWGEOVAX LABS, INC.Condensed Consolidated Statements of Operations Information(amounts in thousands, except per share data)Three Months EndedMarch 31, 2012

2011RevenuesGrant Revenue$
854

$
893Operating expenses:Research and development1,072

838General and administrative513

6621,585

1,500Other income:Interest income1

11

1Net loss$
(730)

$
(606)Loss per common share$  (0.04)

$
(0.04) GEOVAX LABS, INC.Condensed Balance Sheet Information(amounts in thousands)March 31,

Dec. 31,2012

2011Assets:Cash and cash equivalents$
2,240

$
,168Other current assets393

250Total current assets2,633

1,418Property, net 158

176Other assets46

51Total assets$
2,837

$
,645Liabilities and stockholders' equityCurrent liabilities$
510

$
941Stockholders' equity2,327

704Total liabilities and stockho
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Larry J. Merlo , President ... will speak before the National Press Club in ... recent move to stop selling tobacco products and its leadership ... health. "Dramatic changes in our health care system ... government," Merlo has said. "CVS Health has a truly unique ...
(Date:9/19/2014)... , Sept. 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... collagenase-based products marketed as XIAFLEX ® in the U.S. ... BioSpecifics, President, Tom Wegman , will present a corporate ... the Biotech Industry Conference. The presentation will ... EDT at the Millennium Broadway Hotel in New ...
(Date:9/19/2014)... LOS ANGELES , Sept. 19, 2014  CytRx ... and development company specializing in oncology, today announced that ... will present at BioCentury,s 2014 NewsMakers in the Biotech ... p.m. Eastern Time. The conference will take place at ... City . A live and archived ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3
... , , , ... right brain fitness exercises can have a significant ... study recently published in BMC Health Services Research, a leading peer-reviewed health ... did just ten hours of special computerized brain exercises had better health ...
... PALO ALTO, Calif., Aug. 3 Telik, Inc. (Nasdaq: ... Phase 1 multicenter, dose escalation study of ezatiostat hydrochloride (TELINTRA, TLK199) ... a leading peer reviewed journal, Blood, 25 June 2009; ... separate Phase 1-2a study in MDS patients involving an intravenous formulation ...
Cached Medicine Technology:Study Shows Brain Fitness can Save Medicare Billions 2Study Shows Brain Fitness can Save Medicare Billions 3Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome 2
(Date:9/21/2014)... accommodate the ever-growing customer base, Angeldress.co.uk decided to implement ... the company has unveiled its 2014 vintage wedding ... gowns, Angeldress.co.uk wants to make sure that all customers ... Its high quality vintage wedding outfits are now available ... off. , Online shopping is becoming more and more ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... http://www.thegranuflolawsuit.com/ ) have been added over the past ... claims that allege serious cardiovascular injuries caused by ... A Case List updated on September 15th shows ... in the U.S. District Court, District of Massachusetts. ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 “Cluster headaches ... so intense and difficult to resolve,” said Steve Young ... can't think of a pain that is more intense.” ... suffers from cluster headaches, or migraines, that medical research ... the serotonin system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) ...
(Date:9/21/2014)... 2014 Developers and plugin specialist of ... a new transition plugin entitled Transpack Vol. 3 from ... quality transitions that will add a level of professionalism ... of Pixel Film Studios. “Blurring the line between professional ... changer.” , Transpack Vol. 3 returns with over 85 ...
(Date:9/21/2014)... C8 lawsuits move forward in the U.S. District ... 20 possible C8 lawsuits selected for bellwether trials ... & Schulte LLC. Court records show these six C8 ... filed that represent individuals who purportedly developed kidney cancer, ... being exposed to water contaminated by the C8 chemical ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4
... Retrieving about 15 eggs from a woman,s ovaries in a ... of achieving a live birth while avoiding complications from fertility ... than 400,000 IVF cycles in the United Kingdom between 1991 ... rates and the number of eggs retrieved in one cycle. ...
... and medical research information provided by traditional medianewspapers (77%), ... 66%), according to a new state poll commissioned by ... social media is not trustworthy for health and medical ... or other mobile device to find health information. ...
... how well someone will control their emotions? To predict ... stress? To accept critical feedback stoically? ... University, finds clues in what psychologists call "hot" and "cold" ... can control their emotions, and one factor that predicts it ...
... hopes are always placed in new cancer therapies. However, ... prolong the life of cancer patients, or even cure ... years, of testing. Researchers are therefore looking for proxy ... can reliably predict as quickly as possible whether the ...
... marital difficulties may have infants who are losing sleep, ... have a continuing impact on the children. Specifically, ... ninth months old was related to child sleep problems ... asleep, according to Anne Mannering, an Oregon State University ...
... selenium can reduce a person,s risk of cancer, a ... no protective effect against non-melanoma skin cancer or prostate ... selenium over a long period of time could have ... scanned the medical literature, looking for trials that studied ...
Cached Medicine News:Health News:Number of Eggs Retrieved Helps Predict IVF Success: Study 2Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 2Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 3Health News:When words get hot, mental multitaskers collect cool 2Health News:When words get hot, mental multitaskers collect cool 3Health News:How to recognize at an early stage whether a new cancer therapy prolongs life 2Health News:Marriage problems related to infants' sleep difficulties 2Health News:Taking additional selenium will not reduce cancer risk 2
... AquaFlow™ Collagen Glaucoma Drainage Device when ... procedure has been proven to significantly ... the complications often associated with penetrating ... medications. As a result, patient outcomes ...
... Control is a device ... a filter between the ... tubing that captures nuclear ... and efficiency of phaco ...
... is an innovative, stat analyzer that measures ... on-board co-oximetry and integrated data management "all ... include pH, PCO 2 , PO 2 ... sodium, potassium, chloride, ionized calcium, ionized magnesium, ...
... Bio-logic has demonstrated continuous innovations in computerized ... first Digital EEG system brings the latest ... VISION is the first Windows XP Pro ... all your EEG needs: epilepsy monitoring, routine ...
Medicine Products: